A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called angiogenesis inhibitors and protein tyrosine kinase inhibitors.

Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la angiogénesis e inhibidor de la proteína tirosina cinasa.